Companies U S Physical Therapy Inc /NV
U S Physical Therapy Inc /NV (USPH): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me U S Physical Therapy Inc /NV’s executive pay brief as a PDF
You get it on this page the moment you ask; press Download and a copy goes to your email too. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO pay, last three years
- $3,372,377FY2023
- $3,636,676FY2024
- $4,468,314FY2025
CEO total pay was $4,468,314 in fiscal 2025, up from $3,636,676 in fiscal 2024.
FY2025: salary $1,003,125 · stock awards $1,955,250 · option awards $0
Frequently asked questions
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Christopher Reading | $1,003,125 | — | $1,955,250 | $0 | $1,506,375 | $0 | $3,564 | $4,468,314 |
| Chief Executive Officer | ||||||||
| Eric Williams | 688,750 | — | 1,173,150 | 0 | 836,875 | 0 | 3,564 | 2,702,339 |
| President, Chief Operating Officer - East | ||||||||
| Graham Reeve | 643,029 | — | 782,100 | 0 | 804,687 | 0 | 3,564 | 2,233,380 |
| Chief Operating Officer - West | ||||||||
| Carey Hendrickson | 514,423 | — | 782,100 | 0 | 592,250 | 0 | 3,564 | 1,892,337 |
| Chief Financial Officer | ||||||||
| Richard Binstein | 424,038 | — | 782,100 | 0 | 531,250 | 0 | 6,448 | 1,743,836 |
| Executive Vice President, General Counsel and Secretary | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Christopher Reading | $4,468,314 | $3,636,676 | $3,372,377 | ↑ +831,638 |
| Eric Williams | 2,702,339 | 2,263,397 | 1,793,156 | ↑ +438,942 |
| Graham Reeve | 2,233,380 | 1,845,671 | 1,912,806 | ↑ +387,709 |
| Carey Hendrickson | 1,892,337 | 1,628,171 | 1,687,970 | ↑ +264,166 |
| Richard Binstein | 1,743,836 | 1,493,979 | 1,497,209 | ↑ +249,857 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The Company's compensation program is designed to attract and retain talented executives, motivate them to pursue corporate objectives, and align their interests with those of stockholders to maximize long-term growth. It emphasizes a balanced mix of cash and equity compensation with a strong focus on performance-based and at-risk pay, ensuring competitive levels relative to peer companies.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Meridian Compensation Partners, LLC |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Carey Hendrickson | PSU | 2026-02-23 | 1,500 | 3,100 | — | 10,000 | $835,500 |
| Richard Binstein | PSU | 2026-02-23 | 1,500 | 3,100 | — | 10,000 | 835,500 |
| Eric Williams | PSU | 2026-02-23 | 2,250 | 4,650 | — | 15,000 | 1,253,250 |
| Christopher Reading | PSU | 2026-02-23 | 3,750 | 7,750 | — | 25,000 | 2,088,750 |
| Graham Reeve | PSU | 2026-02-23 | 1,500 | 3,100 | — | 10,000 | 835,500 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Carey Hendrickson | $0 | $835,500 | $0 | 100.0% |
| Richard Binstein | 0 | 835,500 | 0 | 100.0% |
| Eric Williams | 0 | 1,253,250 | 0 | 100.0% |
| Christopher Reading | 0 | 2,088,750 | 0 | 100.0% |
| Graham Reeve | 0 | 835,500 | 0 | 100.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Richard Binstein | RSU | 12,624 | — | $985,808 |
| Carey Hendrickson | RSU | 12,796 | — | 999,240 |
| Graham Reeve | RSU | 13,348 | — | 1,042,345 |
| Eric Williams | RSU | 16,322 | — | 1,274,585 |
| Christopher Reading | RSU | 29,946 | — | 2,338,483 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Dr. Bernard A. Harris JrIndependent · Lead Independent Director · Governance and Nominating (Chair) · Audit | $120,000 | $149,431 | $0 | $0 | $0 | $269,431 |
| Kathleen A. GilmartinIndependent · Governance and Nominating · Compliance · Compensation (Chair) | 85,000 | 149,431 | 0 | 0 | 0 | 234,431 |
| Regg E. SwansonIndependent · Governance and Nominating · Compliance (Chair) · Compensation | 85,000 | 149,431 | 0 | 0 | 0 | 234,431 |
| Anne B. MotsenbockerIndependent · Governance and Nominating · Compensation · Audit (Chair) | 80,000 | 149,431 | 0 | 0 | 0 | 229,431 |
| Clayton K. TrierIndependent · Governance and Nominating · Compensation · Audit · Not standing for re-election | 80,000 | 149,431 | 0 | 0 | 0 | 229,431 |
| Nancy J. HamIndependent · Governance and Nominating · Compliance · Not standing for re-election | 65,000 | 149,431 | 0 | 0 | 0 | 214,431 |
| Michael G. MayrsohnEmployee director | 0 | 0 | 0 | 0 | 180,700 | 180,700 |
| Christopher J. ReadingEmployee director · Board Chair | — | — | — | — | — | 0 |
| Peter F. MinanIndependent | — | — | — | — | — | — |
Board fee structure and ownership guideline
| Annual cash retainer | $65,000 |
|---|---|
| Annual equity retainer | $150,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 30,000 / 20,000 / 20,000 |
| Stock ownership guideline | — |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $515,000 |
| Equity awards (grant-date value) | $896,586 |
| All other compensation | $180,700 |
| Total cost of the board | $1,592,286 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names U S Physical Therapy Inc /NV as a peer
Companies that benchmark against USPH
5 companies name USPH as a compensation peer
- Addus HomeCare CorpADUSFY2025
- Enhabit, Inc.EHABFY2024
- RadNet, Inc.RDNTFY2025
- WORTHINGTON ENTERPRISES, INC.WORFY2026
- Worthington Steel, Inc.WSFY2025
Each company listed discloses USPH in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named USPH in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Disclosed peer group — fiscal year 2025
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Peer reciprocity
The companies U S Physical Therapy Inc /NV names as compensation peers that name it back in their own disclosed peer groups.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Astrana Health, Inc. | 2025 | Brandon Sim | $850,000 | $11,999,980 | $0 | $2,059,125 | $14,930,231 |
| 2 | Addus HomeCare Corporation | 2025 | R. Dirk Allison | 1,076,923 | 9,767,870 | 0 | 1,320,000 | 12,190,449 |
| 3 | RadNet, Inc. | 2025 | Howard Berger | 3,000,000 | 8,999,966 | 0 | 0 | 12,087,934 |
| 4 | Concentra Group Holdings, Inc. | 2025 | William Newton | 843,077 | 4,356,000 | 0 | 2,125,000 | 7,399,513 |
| 5 | Surgery Partners, Inc. | 2025 | J. Eric Evans | 1,050,000 | 5,000,000 | 0 | 0 | 6,083,862 |
| 6 | U S Physical Therapy Inc /NV | 2025 | Christopher Reading | 1,003,125 | 1,955,250 | 0 | 1,506,375 | 4,468,314 |
| 7 | The Pennant Group, Inc. | 2025 | Brent Guerisoli | 444,711 | 662,117 | 885,588 | 1,737,874 | 3,739,476 |
| 8 | Enhabit, Inc. | 2024 | Barbara Jacobsmeyer | 850,000 | 2,065,211 | 0 | 223,125 | 3,140,924 |
| 9 | National Healthcare Corp. | 2025 | Stephen Flatt | 577,000 | 505,215 | 300,481 | 1,280,000 | 2,685,370 |
| 10 | Cross Country Healthcare, Inc. | 2025 | Kevin Clark | 18,269 | 2,177,134 | 0 | 0 | 2,355,403 |
| 11 | Corvel Corporation | 2026 | Michael Combs | 679,327 | 0 | 101,716 | 498,809 | 1,285,043 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| U S Physical Therapy Inc /NV | not disclosed | not disclosed | not disclosed | Meridian Compensation Partners, LLC |
| Addus HomeCare Corporation | not disclosed | Restricted Stock 100 | not disclosed | FW Cook |
| Astrana Health, Inc. | 193.8% | PSU 67 · RSU 33 | No | Pearl Meyer |
| Concentra Group Holdings, Inc. | not disclosed | Restricted Stock 100 | not disclosed | not disclosed |
| Corvel Corporation | CEO: 75%, EVP Risk: 61%, CIO: 49%, VP Accounting: 28%% | not disclosed | No | not disclosed |
| Cross Country Healthcare, Inc. | 20% | RSU 60 · PSU 40 | No | Pearl Meyer |
| Enhabit, Inc. | not disclosed | PSU 60 · RSU 40 | not disclosed | Pay Governance |
| National Healthcare Corp. | not disclosed | not disclosed | not disclosed | false |
| RadNet, Inc. | not disclosed | RSU 100 | No | Pearl Meyer |
| Surgery Partners, Inc. | not disclosed | PSU 60 · Restricted Stock 40 | No | Frederic W. Cook & Co., Inc. (FW Cook) |
| The Pennant Group, Inc. | not disclosed | not disclosed | not disclosed | The Company engages periodically with a Compensation Adviser to review and advise the Compensation Committee on the Company's executive compensation. The Compensation Committee did not retain a Compensation Adviser relating to executive compensation in 2025, but did reference compensation studies performed for the Company previously. |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-05-19 | 13,203,434 | 894,885 | 9,913 | 93.65% | Passed |
| 2025 | 2025-05-20 | 12,429,355 | 1,166,532 | 2,075 | 91.42% | Passed |
| 2024 | 2024-05-21 | 13,582,464 | 577,982 | 3,259 | 95.92% | Passed |
| 2023 | 2023-05-16 | 10,536,366 | 1,294,634 | 3,877 | 89.06% | Passed |
| 2022 | 2022-05-17 | 11,502,365 | 254,072 | 5,318 | 97.84% | Passed |
| 2021 | 2021-05-18 | 11,177,022 | 630,135 | 19,584 | 94.66% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-05-19 | 93.65%a |
| 2025 | 2025-05-20 | 91.42%b |
| 2024 | 2024-05-21 | 95.92%c |
a. Approved under the standard stated in the filing — “The approval of the compensation of the NEOs will require the affirmative vote of holders of a majority of votes cast on this matter in person or by proxy. || Abstentions: Accordingly, abstentions applicable to shares present at the meeting will not be included in the tabulation of votes cast on this matter.”.
b. Approved under the standard stated in the filing — “The approval of the compensation of the Named Executive Officers will require the affirmative vote of holders of a majority of votes cast on this matter in person or by proxy. || Abstentions: Accordingly, abstentions applicable to shares present at the meeting will not be included in the tabulation of votes cast on this matter.”.
c. Approved under the standard stated in the filing — “Accordingly, abstentions applicable to shares present at the meeting will not be included in the tabulation of votes cast on this matter.”.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | 92.8 : 1 |
|---|---|
| CEO total compensation | $4,468,314 |
| Median employee compensation | $48,133 |
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Kathleen A. Gilmartin | Director | 2026-05-19 | A | 2,306 | $62 | $142,073 | Common | Form 4 ↗ |
| Dr. Bernard A. Harris Jr | Director | 2026-05-19 | A | 2,306 | 62 | 142,073 | Common | Form 4 ↗ |
| Peter F. Minan | Director | 2026-05-19 | A | 2,306 | 62 | 142,073 | Common | Form 4 ↗ |
| Regg E. Swanson | Director | 2026-05-19 | A | 2,306 | 62 | 142,073 | Common | Form 4 ↗ |
| Anne B. Motsenbocker | Director | 2026-05-19 | A | 2,306 | 62 | 142,073 | Common | Form 4 ↗ |
| Kathleen A. Gilmartin | Director | 2026-05-19 | A | 2,306 | 0 | 0 | Common | Form 4 ↗ |
| Dr. Bernard A. Harris Jr | Director | 2026-05-19 | A | 2,306 | 0 | 0 | Common | Form 4 ↗ |
| Peter F. Minan | Director | 2026-05-19 | A | 2,306 | 0 | 0 | Common | Form 4 ↗ |
| Anne B. Motsenbocker | Director | 2026-05-19 | A | 2,306 | 0 | 0 | Common | Form 4 ↗ |
| Regg E. Swanson | Director | 2026-05-19 | A | 2,306 | 0 | 0 | Common | Form 4 ↗ |
| Graham Reeve | COO | 2026-05-20 | D | 762 | 62 | 47,427 | Common | Form 4 ↗ |
| Jason Travis Curtis | Interim CFO | 2026-05-20 | D | 40 | 62 | 2,490 | Common | Form 4 ↗ |
| Peter F. Minan | Director | 2026-06-08 | A | 492 | 63 | 31,065 | Common | Form 4 ↗ |
| Peter F. Minan | Director | 2026-06-09 | A | 288 | 62 | 17,712 | Common | Form 4 ↗ |
| Peter F. Minan | Director | 2026-06-12 | A | 0.87 | 67 | 58 | Common | Form 4 ↗ |
| Graham Reeve | COO | 2026-08-20 | D | 762 | 78 | 59,436 | Common | Form 4 ↗ |
| Richard Binstein | EVP Gen'l Counsel & Secretary | 2026-08-20 | D | 450 | 78 | 35,100 | Common | Form 4 ↗ |
| Jason Travis Curtis | Interim CFO | 2026-08-20 | D | 40 | 78 | 3,120 | Common | Form 4 ↗ |
| Eric Williams | President and COO | 2026-08-20 | D | 714 | 78 | 55,692 | Common | Form 4 ↗ |
| Peter F. Minan | Director | 2026-09-11 | A | 5.27 | 79 | 416 | Common | Form 4 ↗ |
| Nchacha Etta | EVP & Chief Financial Officer | 2026-09-14 | A | 6,831 | 0 | 0 | Common | Form 4 ↗ |
| Myra Davis | Director | 2026-10-01 | A | 1,210 | 0 | 0 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
Sources (62 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Christopher Reading. DEF 14A, filed 2026-04-16. Section “Executive Compensation” · page 30. As printed: 4,468,314. View filing ↗
- Section 01, Eric Williams. DEF 14A, filed 2026-04-16. Section “Executive Compensation”. As printed: 2,702,339. View filing ↗
- Section 01, Graham Reeve. DEF 14A, filed 2026-04-16. Section “Executive Compensation”. As printed: 2,233,380. View filing ↗
- Section 01, Carey Hendrickson. DEF 14A, filed 2026-04-16. Section “Executive Compensation”. As printed: 1,892,337. View filing ↗
- Section 01, Richard Binstein. DEF 14A, filed 2026-04-16. Section “Executive Compensation”. As printed: 1,743,836. View filing ↗
- Section 03, Carey Hendrickson PSU. DEF 14A, filed 2026-04-16. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Richard Binstein PSU. DEF 14A, filed 2026-04-16. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Eric Williams PSU. DEF 14A, filed 2026-04-16. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Christopher Reading PSU. DEF 14A, filed 2026-04-16. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Graham Reeve PSU. DEF 14A, filed 2026-04-16. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2026-04-16. Section “CEO Pay Ratio”. As printed: 92.8 : 1. View filing ↗
- Section 08, Dr. Bernard A. Harris Jr. DEF 14A, filed 2026-04-16. Section “Director Compensation”. As printed: 269,431. View filing ↗
- Section 08, Kathleen A. Gilmartin. DEF 14A, filed 2026-04-16. Section “Director Compensation”. As printed: 234,431. View filing ↗
- Section 08, Regg E. Swanson. DEF 14A, filed 2026-04-16. Section “Director Compensation”. As printed: 234,431. View filing ↗
- Section 08, Anne B. Motsenbocker. DEF 14A, filed 2026-04-16. Section “Director Compensation”. As printed: 229,431. View filing ↗
- Section 08, Clayton K. Trier. DEF 14A, filed 2026-04-16. Section “Director Compensation”. As printed: 229,431. View filing ↗
- Section 08, Nancy J. Ham. DEF 14A, filed 2026-04-16. Section “Director Compensation”. As printed: 214,431. View filing ↗
- Section 08, Michael G. Mayrsohn. DEF 14A, filed 2026-04-16. Section “Director Compensation”. As printed: 180,700. View filing ↗
- Section 08, Christopher J. Reading. DEF 14A, filed 2026-04-16. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Peter F. Minan. DEF 14A, filed 2026-04-16. Section “Director Compensation”. As printed: —. View filing ↗
- Section 02, Kathleen A. Gilmartin 2026-05-19. Form 4, filed 2026-05-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dr. Bernard A. Harris Jr 2026-05-19. Form 4, filed 2026-05-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Peter F. Minan 2026-05-19. Form 4, filed 2026-05-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Regg E. Swanson 2026-05-19. Form 4, filed 2026-05-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Anne B. Motsenbocker 2026-05-19. Form 4, filed 2026-05-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kathleen A. Gilmartin 2026-05-19. Form 4, filed 2026-05-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dr. Bernard A. Harris Jr 2026-05-19. Form 4, filed 2026-05-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Peter F. Minan 2026-05-19. Form 4, filed 2026-05-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Anne B. Motsenbocker 2026-05-19. Form 4, filed 2026-05-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Regg E. Swanson 2026-05-19. Form 4, filed 2026-05-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Graham Reeve 2026-05-20. Form 4, filed 2026-06-22. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jason Travis Curtis 2026-05-20. Form 4, filed 2026-06-22. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Peter F. Minan 2026-06-08. Form 4, filed 2026-06-10. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Peter F. Minan 2026-06-09. Form 4, filed 2026-06-10. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Peter F. Minan 2026-06-12. Form 4, filed 2026-09-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Graham Reeve 2026-08-20. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Binstein 2026-08-20. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jason Travis Curtis 2026-08-20. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Eric Williams 2026-08-20. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Peter F. Minan 2026-09-11. Form 4, filed 2026-09-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Nchacha Etta 2026-09-14. Form 4, filed 2026-09-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Myra Davis 2026-10-01. Form 4, filed 2026-10-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-05-19. Item 5.07 · say-on-pay result. As reported: 93.65% (votes for as printed: 13,203,434). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-05-20. Item 5.07 · say-on-pay result. As reported: 91.42% (votes for as printed: 12,429,355). View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-05-21. Item 5.07 · say-on-pay result. As reported: 95.92% (votes for as printed: 13,582,464). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 515,000 + equity 896,586 + all other 180,700 = 1,592,286, summed across the director compensation table rows.
- Astrana Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-17. CEO total compensation as printed in Astrana Health, Inc.'s own proxy. As printed: 14,930,231. View filing ↗
- Addus HomeCare Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-23. CEO total compensation as printed in Addus HomeCare Corporation's own proxy. As printed: 12,190,449. View filing ↗
- RadNet, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-20. CEO total compensation as printed in RadNet, Inc.'s own proxy. As printed: 12,087,934. View filing ↗
- Concentra Group Holdings, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-17. CEO total compensation as printed in Concentra Group Holdings, Inc.'s own proxy. As printed: 7,399,513. View filing ↗
- Surgery Partners, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-23. CEO total compensation as printed in Surgery Partners, Inc.'s own proxy. As printed: 6,083,862. View filing ↗
- U S Physical Therapy Inc /NV (subject), Section 10b CEO total. DEF 14A, filed 2026-04-16. CEO total compensation as printed in U S Physical Therapy Inc /NV's own proxy. As printed: 4,468,314. View filing ↗
- The Pennant Group, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-31. CEO total compensation as printed in The Pennant Group, Inc.'s own proxy. As printed: 3,739,476. View filing ↗
- Enhabit, Inc., Section 10b CEO total. DEF 14A, filed 2025-05-16. CEO total compensation as printed in Enhabit, Inc.'s own proxy. As printed: 3,140,924. View filing ↗
- National Healthcare Corp., Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in National Healthcare Corp.'s own proxy. As printed: 2,685,370. View filing ↗
- Cross Country Healthcare, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-30. CEO total compensation as printed in Cross Country Healthcare, Inc.'s own proxy. As printed: 2,355,403. View filing ↗
- Corvel Corporation, Section 10b CEO total. DEF 14A, filed 2026-06-26. CEO total compensation as printed in Corvel Corporation's own proxy. As printed: 1,285,043. View filing ↗
- Section 10a, RadNet, Inc. reciprocity. DEF 14A. RadNet, Inc. names U S Physical Therapy Inc /NV in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Enhabit, Inc. reciprocity. DEF 14A. Enhabit, Inc. names U S Physical Therapy Inc /NV in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Addus HomeCare Corporation reciprocity. DEF 14A. Addus HomeCare Corporation names U S Physical Therapy Inc /NV in its own disclosed peer group (read from its most recent proxy). View filing ↗